Filing Flows

Filing Flows › Companies › Si-Bone › Cash flow

Si-Bone cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$427K in Q3 2026 · −$4.2M over twelve months

Operating cash flow$5.9M
Capital spending−$6.4M
Free cash flow−$427K
Cash conversion cycle298 days

Analysis

In Q3 2026, Si-Bone generated $5.9M of operating cash flow and spent $6.4M on capital projects, leaving free cash flow of −$427K. That is $193K more than in Q3 2025 (−$620K).

Over the twelve months to Sep 30, 2026, operating cash flow was $6.1M; the largest uses were capital spending ($10.3M); besides operations, cash came from other investing ($10.3M), other financing ($1.8M); the cash balance rose by $8.8M.

Operating cash flow was $5.9M against net income of −$3.6M. The largest differences: stock-based pay +$5.7M, inventory −$4.1M, accrued liabilities +$4.0M.

Its cash conversion cycle was 298 days (receivables 52 + inventory 322 − payables 76).

Free cash flow

Si-Bone: free cash flow by quarterSi-Bone: free cash flow by quarter−$1.1MQ4 2024−$7.0MQ1 2025−$1.9MQ2 2025−$620KQ3 2025$440KQ4 2025−$3.4MQ1 2026−$768KQ2 2026−$427KQ3 2026
Operating cash flow less capital spending.
Si-Bone: operating cash flow against capital spendingSi-Bone: operating cash flow against capital spendingOperating cash flowCapital spending$1.2M$2.3MQ4 2024−$4.9M$2.1MQ1 2025$173K$2.1MQ2 2025$2.3M$3.0MQ3 2025$1.7M$1.3MQ4 2025−$2.4M$1.1MQ1 2026$777K$1.5MQ2 2026$5.9M$6.4MQ3 2026
Latest (Q3 2026): Operating cash flow $5.9M, Capital spending $6.4M.

Capital allocation, year by year

Si-Bone: where the cash came from (up) and went (down), by fiscal yearSi-Bone: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2021: Operating cash flow −$39.5MFY2021: Net borrowing −$6.0MFY2021: Shares issued $2.6MFY2021: Capital spending −$6.4M$2.6MFY2021FY2022: Operating cash flow −$41.7MFY2022: Shares issued $379KFY2022: Capital spending −$9.5M$379KFY2022FY2023: Operating cash flow −$18.7MFY2023: Net borrowing $685KFY2023: Shares issued $88.1MFY2023: Capital spending −$7.8M$88.7MFY2023FY2024: Operating cash flow −$12.4MFY2024: Net borrowing −$46KFY2024: Shares issued $570KFY2024: Capital spending −$10.5M$570KFY2024FY2025: Operating cash flow −$675KFY2025: Shares issued $1.2MFY2025: Capital spending −$8.4M$1.2MFY2025
Over these 5 years operating cash flow totalled −$113M; the largest uses were operating cash flow ($113M) and capital spending ($42.6M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$35.3M
Debt$35.7M
Net debt$346K

Si-Bone's operations bring cash in ($6.1M over twelve months), and it spends more than that on capital projects: a gap of $4.2M funded from its $35.3M of cash and investments and from borrowing ($35.7M of debt). That is a choice to invest, not a cash runway running down.

Si-Bone: debt maturities by year (FY2025)Si-Bone: debt maturities by year (FY2025)$6.0MYear 2$18.0MYear 3$12.0MYear 4
Principal due in each year as disclosed in the annual report, against $35.3M of cash and investments now.

Where the cash came from and went

Si-Bone: sources (+) and uses (−) of cash, Q3 2026Si-Bone: sources (+) and uses (−) of cash, Q3 2026Capital spending−$6.4MOperating cash flow$5.9MOther investing$2.3MCash drawn (+) / kept (−)−$2.2MShares issued$347KExchange rates−$24K
Si-Bone: sources (+) and uses (−) of cash, TTM to Q3 2026Si-Bone: sources (+) and uses (−) of cash, TTM to Q3 2026Capital spending−$10.3MOther investing$10.3MCash drawn (+) / kept (−)−$8.8MOperating cash flow$6.1MOther financing$1.8MShares issued$1.2MExchange rates−$273K

From profit to cash

Si-Bone: net income to operating cash flow, Q3 2026Si-Bone: net income to operating cash flow, Q3 2026Net income−$3.6MDepreciation & amortization$1.7MStock-based pay$5.7MGains on disposals$23KReceivables−$302KInventory−$4.1MPayables$3.0MAccrued liabilities$4.0MPrepaid and other assets−$155KOperating cash flow$5.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20265232276298
Q2 20265029361283
Q1 20265229448297
Q4 20254627148269
Q3 20254832871305
Q2 20254829970277
Q1 20255226967254
Q4 20244923762224

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$5.9M−$6.4M—$347K−$2.2M−$427K
Q2 2026$777K−$1.5M—$438K$407K−$768K
Q1 2026−$2.4M−$1.1M—$34K$8.7M−$3.4M
Q4 2025$1.7M−$1.3M—$390K−$15.8M$440K
Q3 2025$2.3M−$3.0M—$11K$7.7M−$620K
Q2 2025$173K−$2.1M—$665K$7.0M−$1.9M
Q1 2025−$4.9M−$2.1M—$103K−$6.2M−$7.0M
Q4 2024$1.2M−$2.3M−$46K$6K−$4.7M−$1.1M

Si-Bone: income statement and cash flow

Si-Bone, Q3 2026: revenue $55.7M (+14% year over year), operating margin -7.8%. The chart follows the revenue to costs, profit and cash.

Si-Bone: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.